A blood test can predict the risk of dementia in women up to 25 years before symptoms appear, researchers say.Experts in the US found that higher levels of a protein called p-tau217 – which is linked ...

The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

Researchers say elevated p-tau217 levels in older women were strongly linked to future dementia, raising hopes for earlier detection and prevention strategies.

Experts say the discovery might mean women could be given help long before memory problems affect their daily life ...

Psychology Today's online self-tests are intended for informational purposes only and are not diagnostic tools. Psychology Today does not capture or store personally identifiable information, and your ...

Early detection is imperative to catch neurodegenerative diseases like dementia in their early stages and slow disease progression. But regular cognitive testing is not yet commonplace in healthcare ...

But here's why you likely won't be seeing it in your doctor's office anytime soon.

Carole Rainey, whose name has been changed to protect her privacy, started to notice something wasn’t quite right with her husband, Bill, when he began to ramble in a way that was unlike him. He had ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

Scientists found that a blood protein called p tau217 may reveal dementia risk up to 25 years before symptoms appear.

Researchers say a new blood test may help identify women at risk of developing dementia decades before symptoms appear, potentially transforming how doctors detect and prevent the disease.